Skip to content

Wearable Devices for Patient Monitoring in Long QT Syndrome

Application of Wearable Devices for Remote QT Interval Monitoring and Symptom Investigation for Patients With Long QT Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06887387
Enrollment
80
Registered
2025-03-20
Start date
2025-04-01
Completion date
2026-09-04
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long QT Syndrome

Brief summary

The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.

Interventions

This is an observational study that does not impact routine clinical care for participants

Sponsors

Queen Mary University of London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Long QT Syndrome * Aged 18 years or over * Phone with iOS version 15 or Android OS 9.0 or higher * Able and willing to provide informed consent

Exclusion criteria

* Unwilling or unable to give consent * Ventricular pacing at recruitment * Bundle branch block or pre-excitation at baseline

Design outcomes

Primary

MeasureTime frame
1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)From enrollment to 3 months
2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.From enrollment to 3 months

Secondary

MeasureTime frame
1. Establish the utility of wearable devices for determining symptom aetiology in LQTS.From enrollment to 3 months
2. Develop pipelines for the analysis of ECG data collected remotely including use of in-house QT automated algorithms for future machine learning applications.From enrollment to 3 months

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORWilliam J Young, MBBS, PhD

Queen Mary University of London and St Bartholomew's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026